Enthera Pharmaceuticals Appoints Kazumi Shiosaki to Its Board of Directors and Lisa Olson to Its Scientific Advisory Board to Push Forward Company Growth and Development
The Pharma Data
DECEMBER 2, 2020
Kazumi was also a co-founder and CEO of Mitobridge, a start-up company developing mitochondrial drugs for the treatment of muscle and kidney diseases, until its acquisition by Astellas Pharma in 2018. Kazumi holds a PhD in Synthetic Chemistry from UC Berkeley. 3, 2020 08:00 UTC.
52 
Let's personalize your content